Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
Nature Immunology
|
March 26, 2026
A transcriptomic microglia taxonomy across mouse and human pathologies
Chintan Chhatbar, Roman Sankowski, Michael Schulz, et al.
Hepatology (Baltimore, Md.)
|
December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
Bernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Journal of Hepatology
|
June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma
Pasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
Cancer Cell
|
February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Lukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Nature Cancer
|
May 13, 2024
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, et al.
Nature
|
February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
Nature Immunology
|
March 26, 2026
A transcriptomic microglia taxonomy across mouse and human pathologies
Chintan Chhatbar, Roman Sankowski, Michael Schulz, et al.
Hepatology (Baltimore, Md.)
|
December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
Bernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Journal of Hepatology
|
June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma
Pasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
Cancer Cell
|
February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Lukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Nature Cancer
|
May 13, 2024
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, et al.
Nature
|
February 4, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki, et al.
Page
of 14